Nina Rawal

Nina Rawal is a seasoned professional and leader in the health and venture capital sectors. Currently serving as Partner and Co-Head of Ventures at Trill Impact since September 2021, Nina manages a significant portfolio with over EUR 1 billion in assets. Nina's involvement with global initiatives includes being a Young Global Leader at the World Economic Forum and holding key board positions at May Health, Cinclus Pharma, and Stockholms Sjukhem. Nina also founded Emerging Health Ventures and previously served as a board member at MedCap AB. With a robust educational background, including a Ph.D. in Molecular Neurobiology from Karolinska Institutet and executive education from Harvard Kennedy School, Nina combines expertise in medicine and leadership to drive impactful changes in healthcare and investment.